EVIDENCE IN FAVOUR OF THE EXISTENCE OF A DOPAMINE-FREE PROLACTIN-INHIBITING FACTOR (PIF) IN RAT HYPOTHALAMIC EXTRACTS.ENJALBERT A; PRIAM M; KORDON C et al.1977; EUROP. J. PHARMACOL.; NETHERL.; DA. 1977; VOL. 41; NO 2; PP. 243-244; BIBL. 5 REF.Article

ENDOGENOUS OPIATES BLOCK DOPAMINE INHIBITION OF PROLACTIN SECRETION IN VITROENJALBERT A; RUBERG M; ARANCIBIA S et al.1979; NATURE; GBR; DA. 1979; VOL. 280; NO 5723; PP. 595-597; BIBL. 27 REF.Article

EFFET DE NEUROPEPTIDES SUR LA SECRETION DE PROLACTINE AU NIVEAU HYPOPHYSAIREENJALBERT A; ARANCIBIA S; RUBERG M et al.1980; J. PHYSIOL.; FRA; DA. 1980; VOL. 76; NO 3; PP. 227-231; ABS. ENG; BIBL. 25 REF.Article

PROLACTIN INHIBITING ACTIVITY OF DOPAMINE-FREE SUBCELLULAR FRACTIONS FROM RAT MEDIOBASAL HYPOTHALAMUS.ENJALBERT A; MOOS F; CARBONELL L et al.1977; NEUROENDOCRINOLOGY; SWITZ.; DA. 1977; VOL. 24; NO 3-4; PP. 147-161; BIBL. 2 P.Article

EFFECT OF SUCKLING ON PLASMA PROLACTIN AND HYPOTHALAMIC MONOAMINE LEVELS IN THE RAT.MENA F; ENJALBERT A; CARBONELL L et al.1976; ENDOCRINOLOGY; U.S.A.; DA. 1976; VOL. 99; NO 2; PP. 445-451; BIBL. 25 REF.Article

STIMULATION OF IN VITRO PROLACTIN RELEASE BY VASO-ACTIVE INTESTINAL PEPTIDEENJALBERT A; ARANCIBIA S; RUBERG M et al.1980; NEUROENDOCRINOLOGY; CHE; DA. 1980; VOL. 31; NO 3; PP. 200-204; BIBL. 42 REF.Article

EFFECT OF MORPHINE ON THE DOPAMINE INHIBITION OF PITUITARY PROLACTIN RELEASE IN VITROENJALBERT A; RUBERG M; FIORE L et al.1979; EUROP. J. PHARMACOL.; NLD; DA. 1979; VOL. 53; NO 2; PP. 211-212; BIBL. 5 REF.Article

LONG LASTING EFFECT OF INTRAUTERINE GROWTH RETARDATION ON 5-HT METABOLISM IN THE BRAIN OF DEVELOPING RATSCHANEZ C; PRIAM M; FLEXOR MA et al.1981; BRAIN RES.; ISSN 0006-8993; NLD; DA. 1981; VOL. 207; NO 2; PP. 397-408; BIBL. 41 REF.Article

EFFECT OF VASOACTIVE INTESTINAL PEPTIDE (VIP) ON SOMATOSTATIN INHIBITION OF PITUITARY GROWTH HORMONE SECRETION IN VITROTAPIA ARANCIBIA L; ARANCIBIA S; BLUET PAJOT MT et al.1980; EUROP. J. PHARMACOL.; NLD; DA. 1980; VOL. 63; NO 2-3; PP. 235-236; BIBL. 5 REF.Article

INDEPENDENT INHIBITION OF PROLACTIN SECRETION BY DOPAMINE AND GAMMA -AMINOBUTYRIC ACID IN VITROENJALBERT A; RUBERG M; ARANCIBIA S et al.1979; ENDOCRINOLOGY; USA; DA. 1979; VOL. 105; NO 3; PP. 823-826; BIBL. 23 REF.Article

INHIBITION OF IN VITRO PROLACTIN SECRETION BY HISTIDYL-PROLINE-DIKETOPIPERAZINE, A DEGRADATION PRODUCT OF TRHENJALBERT A; RUBERG M; ARANCIBIA S et al.1979; EUROP. J. PHARMACOL.; NLD; DA. 1979; VOL. 58; NO 1; PP. 97-98; BIBL. 5 REF.Article

An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cellsJOURNOT, L; HOMBURGER, V; PANTALONI, C et al.The Journal of biological chemistry (Print). 1987, Vol 262, Num 31, pp 15106-15110, issn 0021-9258Article

Involvement of protein kinase-C in the effect of angiotensin-II on adenosine 3',5'-monophosphate production in lactotroph cellsAUDINOT, V; RASOLONJANAHARY, R; BERTRAND, P et al.Endocrinology (Philadelphia). 1991, Vol 129, Num 4, pp 2231-2239, issn 0013-7227Article